tiprankstipranks
Trending News
More News >
Immunicum AB (DE:1YG0)
:1YG0
Germany Market
Advertisement

Immunicum AB (1YG0) Income Statement

Compare
1 Followers

Immunicum AB Income Statement

Last quarter (Q1 2025), Immunicum AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q1, Immunicum AB's net income was kr-30.48M. See Immunicum AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 5.05Mkr 28.49Mkr 3.00Mkr 6.00Kkr 0.00
Gross Profit
kr -6.52Mkr 28.49Mkr -1.85Mkr -1.84Mkr -1.77M
Operating Expenses
kr 128.63Mkr 123.40Mkr 134.70Mkr 129.28Mkr 85.96M
Depreciation and Amortization
kr 6.52Mkr 3.37Mkr 4.85Mkr 1.85Mkr 1.77M
EBITDA
kr -124.16Mkr -97.85Mkr -128.67Mkr -128.28Mkr -84.25M
Operating Income
kr -130.66Mkr -100.65Mkr -133.68Mkr -130.10Mkr -86.03M
Other Income/Expenses
kr 2.26Mkr -969.00Kkr -5.10Mkr -3.31Mkr -3.22M
Pretax Income
kr -128.40Mkr -101.62Mkr -138.78Mkr -133.41Mkr -89.25M
Net Income
kr -128.40Mkr -101.62Mkr -136.99Mkr -136.69Mkr -92.47M
Per Share Metrics
Basic EPS
kr -2.64kr -4.40kr -0.63kr -0.68kr -1.12
Diluted EPS
kr -2.64kr -4.39kr -0.63kr -0.68kr -1.12
Weighted Average Shares Outstanding
48.64M 23.10M 216.49M 199.75M 82.75M
Weighted Average Shares Outstanding (Diluted)
48.64M 23.13M 216.49M 199.75M 82.75M
Currency in SEK

Immunicum AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis